Elevated 68Ga prostate-specific membrane antigen activity in metastatic non-small cell lung cancer

Clinical Nuclear Medicine

Volumn 41, Issue 5, 2016, Pages 414-416

  Shetty, Deepa ^a   Loh, Han ^a,b   Bui, Chuong ^a,b   Mansberg, Robert ^a,b   Stevanovic, Amanda ^a  

^a NEPEAN HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

68Ga PSMA PET CT; Endothelial cells; Lung cancer; Prostate cancer; Tumor neovascularity neovasculature

Indexed keywords

PROSTATE SPECIFIC MEMBRANE ANTIGEN; PROSTATE SPECIFIC MEMBRANE ANTIGEN GA 68; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; (68GA)GLU-UREA-LYS(AHX)-HBED-CC; ORGANOMETALLIC COMPOUND; PROSTATE SPECIFIC ANTIGEN;

AGED; ARTICLE; BLADDER DIVERTICULUM; CANCER STAGING; CASE REPORT; COMPUTER ASSISTED EMISSION TOMOGRAPHY; ECHOGRAPHY; FINE NEEDLE ASPIRATION BIOPSY; HUMAN; LUNG LOBE; LUNG METASTASIS; LYMPHADENOPATHY; MALE; NON SMALL CELL LUNG CANCER; PELVIS LYMPH NODE; PRIMARY TUMOR; PROSTATE CANCER; SUPRACLAVICULAR LYMPH NODE; THYROID DISEASE; ADENOCARCINOMA; DIAGNOSTIC IMAGING; LUNG TUMOR; LYMPH NODE METASTASIS; METABOLISM; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; PROSTATE TUMOR; SECONDARY; X-RAY COMPUTED TOMOGRAPHY;

ADENOCARCINOMA; AGED; CARCINOMA, NON-SMALL-CELL LUNG; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; ORGANOMETALLIC COMPOUNDS; POSITRON-EMISSION TOMOGRAPHY; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 85008397746     PISSN: 03639762     EISSN: 15360229     Source Type: Journal    
DOI: 10.1097/RLU.0000000000001139     Document Type: Article

References (12)

1. Turner BM, Cagle PT, Sainz IM, et al. Napsin A, a new marker for lung ad-enocarcinoma, is complementary and more sensitive and specific than thyroid transcription factor 1 in the differential diagnosis of primary pulmonary carcinoma: evaluation of 1674 cases by tissue microarray. Arch Pathol Lab Med. 2012;136:163-171.
2. Chang SS. Overview of prostate-specific membrane antigen. Rev Urol. 2004;6(suppl 10):S13-S18.
3. Afshar-Oromieh A, Avtzi E, Giesel FL, et al. The diagnostic value of PET/CT imaging with the (68)Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer. Eur J Nucl Med Mol Imaging. 2015;42: 197-209.
4. Wang HL, Wang SS, Song WH, et al. Expression of prostate-specific membrane antigen in lung cancer cells and tumor neovasculature endothelial cells and its clinical significance. PLoS One. 2015;10:e0125924.
5. Chang SS, O'Keefe DS, Bacich DJ, et al. Prostate-specific membrane antigen is produced in tumor-associated neovasculature. Clin Cancer Res. 1999;5:2674-2681.
6. 68Ga]PSMA-HBED-CC PET/CT. Eur J Nucl Med Mol Imaging. 2015;42:1622-1623.
7. Wernicke AG, Varma S, Greenwood EA, et al. Prostate-specific membrane antigen expression in tumor-associated vasculature of breast cancers. APMIS. 2013;122:482-489.
8. Wang W, Tavora F, Sharma R, et al. PSMA expression in Schwannoma: a potential clinical mimicker of metastatic prostate carcinoma. Urol Oncol. 2009; 27:525-528.
9. Silver DA, Pellicer I, Fair WR, et al. Prostate-specific membrane antigen expression in normal and malignant human tissues. Clin Cancer Res. 1997;3: 81-85.
10. Nomura N, Pastorino S, Jiang P, et al. Prostate specific membrane antigen (PSMA) expression in primary gliomas and breast cancer brain metastases. Cancer Cell Int. 2014;14:26.
11. Kobe C, Maintz D, Fischer T, et al. Prostate-specific membrane antigen PET/CT in splenic sarcoidosis. Clin Nucl Med. 2015;40:897-898.
12. Artigas C, Alexiou J, Garcia C, et al. Paget bone disease demonstrated on (68)Ga-PSMA ligand PET/CT. Eur J Nucl Med Mol Imaging. 2016;43: 195-196.